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ABSTRACT

Embryonic stem cells (ESCs) are a promising cell source for regenerative
medicine. However, recent studies indicated that ESCs and ESC-derived cells (ESC-DCs)
lack functional innate immunity against various pathogens and inflammatory cytokines.
This presents a barrier to clinical application, as ESC-DCs would be placed in a wound
site and exposed to pathogens and inflammatory cytokines. Using mouse ESCs (mESCs)
as a model, we recently demonstrated that they are deficient in expressing type I
interferons (IFN) and inflammatory cytokines. To determine the molecular basis for this
finding, this study examined the activation state of nuclear factor-κB (NF-κB), a
transcription factor that plays a key role in mediating the antiviral and inflammatory
responses. Our results indicated that NF-κB in mESCs was not activated by TNFα, a
cytokine that is known to induce strong inflammatory responses in differentiated cells.
However, NF-κB was activated when mESCs were differentiated to fibroblasts (ESCFBs). This was confirmed by NF-κB translocation from the cytoplasm to the nucleus
upon TNFα treatment. Once in the nucleus, NF-κB activates transcription of immune
related genes, but the expression of its regulated genes was much lower than in naturally
differentiated FBs. Further analysis by RT-qPCR revealed that the expression of some
NF-κB pathway components is upregulated in ESC-FBs. We conclude that the lack of
innate immunity in mESCs is, at least partly, due to the inactivated status of NF-κB in
mESCs.
Key Words: NF-κB, innate immunity, mESCs, differentiation, regenerative medicine
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INTRODUCTION
Stem Cells
Background
Stem cells are characterized by their capacity of self-renewal and cell potency.
Self-renewal is defined as the ability of stem cells to proliferate while maintaining their
undifferentiated state. Cell potency is the ability of a cell to differentiate into more
mature cell types. There are two general categories of stem cells: embryonic stem cells
(ESCs) and adult stem cells. An ESC is pluripotent meaning it can differentiate into any
cell type of the adult organism. ESCs are important in early development of an organism.
Adult stem cells, however, play a role in tissue repair throughout an organism’s life and
have limited differentiation potential. Adult stem cells can be either multipotent or
unipotent. A multipotent cell can differentiate into several similar cell types, while a
unipotent cell can only differentiate into one cell type (Li & Xie, 2005).
Since this research is focused on ESCs, the following introduction is a brief
discussion of ESCs and their roles in organism development, in vitro derivation, and
basic characterization. ESCs are derived from the inner cell mass (ICM) of blastocysts.
As shown in Figure 1, the isolation of ESCs from the ICM can be better understood with
a basic explanation of mouse embryogenesis. First, a zygote is formed by the fertilization
of an egg by a sperm. A zygote is totipotent, meaning that it has the potential to give rise
to all the cells of the embryo as well as extra-embryonic tissues like the placenta. Further
cell divisions and differentiation yield a blastocyst, composed of an outer layer of
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differentiated cells known as trophoblasts and an ICM of undifferentiated, pluripotent
cells (Wobus & Boheler, 2005). These cells are able to develop into any cell type derived
from the embryo proper. When these cells are harvested and cultured in vitro, they are
termed ESCs (Niwa, 2007).

Figure 1: An overview of mouse embryogenesis and ESC derivation (image from Wobus
& Boheler, 2005).
ESCs, due to their pluripotent nature, have the ability to differentiate into cells of
any of the three primary germ layers: ectoderm, mesoderm, and endoderm. Once a cell
differentiates into tissue cells of one of the primary germ layers, they become multipotent
(only able to differentiate into cells of that particular tissue type). The inner germ layer,
the endoderm, has the potential to develop cells such as lung cells or liver cells. The
middle germ layer, the mesoderm, has the potential to develop into cells such as red
blood cells, muscle cells, and fibroblasts. The outer germ layer, the ectoderm, has the
potential to develop cells such as epithelial cells and neurons (Wobus & Boheler, 2005).
2

As embryonic development progresses, organ development becomes necessary to
form a functional organism. This is the point at which multipotent and unipotent adult
stem cells form. Once the embryo is fully developed and exits the uterus, these adult
stem cells reside in “stem cell niches” where they can repair damaged tissue as needed
throughout the organism’s life. For example, hematopoietic stem cells reside in the bone
marrow where they can be induced to differentiate into various types of blood cells as
needed (Li & Xie, 2005).
Characteristics of ESCs
The most defining characteristic of ESCs is their ability to maintain their
undifferentiated pluripotent state during in vitro propagation. The ability of ESCs to
maintain pluripotency requires the careful maintenance of signals the cell receives. The
cell must keep a perfect balance of promoting proliferation while down regulating
differentiation. This delicate process is mediated by many transcription factors. The
main transcription factors regulating this process are Oct3/4, Sox2, Nanog, and Stat3.
Oct3/4 prevents differentiation of ESCs. Sox2 shares a similar role, often interacting
with Oct3/4. Stat3 is the transcription factor activated by the JAK/STAT (Janus kinase
signal transducer and activator of transcription) pathway promoting pluripotency in cells.
Nanog seems to repress factors promoting differentiation, thereby promoting
pluripotency and self-renewal. Specific expression levels of each of these transcription
factors are vital for maintaining pluripotency through self-renewal. For example,
overexpression of Oct3/4 and inhibition of Stat3 can cause differentiation (Niwa, 2007).
There are also significant differences between the cell cycles of ESCs and somatic
cells. The mechanism of cell cycle regulation varies between the two. The G1 phase is
3

much shorter in ESCs than in somatic cells, and most ESCs are found in the S phase. As
these cells differentiate, their cell cycle becomes more like somatic cells (White &
Dalton, 2005).
ESCs also have a distinct morphology, as shown in Figure 2. ESCs have a
distinctly round shape and a large nucleus-to-cytoplasm ratio. ESCs also have a tendency
to form tightly packed colonies in vitro.

Figure 2: Morphology of a mESC colony (stained with toluidine blue)
Maintenance of ESC pluripotency and Differentiation
The first pluripotent cell lines were derived from teratocarcinomas, a germ cell
tumor that occurs in the testes of mice and humans. It was discovered that these
malignant tumors were not only composed of germ cells, but also embryonal carcinoma
stem cells (Wobus & Boheler, 2005). In 1970, Kahan and Ephrussi created an embryonal
carcinoma stem cell line by isolating these cells from a teratocarcinoma and propagating
them in vitro. These cells were able to maintain their undifferentiated state in vitro for
about 119 generations and were able to be differentiated into neural and mesenchymal
cell types in vitro (Kahan & Ephrussi, 1970). While embryonal carcinoma stem cell lines
made a good model for the study of embryonic cells, isolation of ESCs themselves from
mouse embryos would allow for their direct study. It was not until 1981 that isolation of
4

ESCs from the ICM of mouse blastocysts was achieved and mouse ESCs (mESCs) were
cultured in vitro. This led to the creation of the first mESC cell lines (Evans & Kaufman,
1981; Martin, 1981). Finally, in 1998 human ESC (hESC) cell lines were created
following the isolation of inner mass cells of human blastocysts from in vitro fertilized
human embryos (Thomson et al. 1998).
To create an ESC culture, inner mass cells are first isolated from a blastocyst,
which forms about 4-5 days after fertilization. These are plated in culture medium
containing bovine serum on a plate with mouse embryonic fibroblasts feeder layers. The
feeder layer supplies factors necessary to maintain the pluripotent state of the ESCs
(Amit et al., 2005). A greater understanding of the molecular mechanisms maintaining
pluripotency in mESCs has permitted the growth of mESC cultures without the use of a
feeder layer. The cytokine leukemia inhibitory factor (LIF) is commonly used in mESC
cultures to inhibit differentiation and maintain a stem cell state. This cytokine activates
JAK/STAT leading to the activation of Stat3, promoting proliferation and pluripotency
while inhibiting differentiation (Niwa, 2007).
Manipulation of transcription factors can also be used to induce in vitro
differentiation. When LIF is removed from mESC culture, Stat3 is inhibited, and
differentiation occurs. Other chemicals such as retinoic acid can be added to culture to
promote differentiation to different cell types as illustrated in Figure 3 (Niwa, 2007).
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Figure 3: ESC differentiation to multiple cell lineages (image from Malliard et al., 2011)
Promises of ESCs in Biomedical Applications and in Basic Research
It has been shown that hESCs can be differentiated into cardiomycetes, neurons,
endothelial cells, and many more cell types, showing great promise for organ replacement
via cell therapy (Grinnemo et al., 2008). However, there are no current therapies utilizing
hESCs due to many issues involving the ethical concerns and technical obstacles to their
clinical application. For example, there is great concern about exposure to viruses by the
mouse feeder layer and accumulation of genetic mutations in hESC cell lines (Hyun,
2010). However, the potential of use of hESCs in regenerative medicine has been
supported by numerous mESC studies (Wobus & Boheler, 2005).
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In order to utilize ESC derived cells (ESC-DCs) for therapeutic application, the
ESC-DCs must fully integrate and function appropriately once transplanted to the
targeted site of the organism. mESC derived cardiomycetes, neural progenitor cells, and
insulin producing cells have all been successfully transplanted into mice integrating fully
into the tissue, functioning just as their in vivo counterparts. These transplants have
successfully treated diseases such as Parkinson’s disease and diabetes in mouse models.
Neural progenitor cells derived from hESCs have been successfully integrated into
mice’s brains, showing specific functions once transplanted (Wobus & Boheler, 2005).
Most of the current knowledge available about stem cells is derived from mESC
research. Some of these findings have been confirmed in hESCs. For example, Oct4,
Sox2, and Nanog play important roles in maintaining pluripotency in both cell types
(Schnerch et al., 2010). However, research has also found great differences between the
two. For example, the use of LIF is not enough to maintain the stem cell state in hESCs,
as it is in mESCs, indicating some differences in the mechanisms involved in maintaining
pluripotency and differentiation potential. It has even been suggested that the
LIF/STAT3 pathway in hESCs isn’t functional (Humphrey et al., 2004). Due to these
differences, some of the research conducted using mESCs may not be applicable to
hESCs (Scherch et al., 2010). For example, although Parkinson’s has been successfully
treated in mouse models from both mESC and hESC derived neural progenitor cells, a
clinical study using hESC derived neural cells to treat human patients had some negative
long term effects and did not seem to improve the patient’s condition despite the success
of the transplant itself (Freed et al., 2001). Further research should be conducted to
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determine the long-term functionality of hESC-DC transplants in human subjects (Wobus
& Boheler, 2005).
In addition to their potential for clinical application, ESCs make a great model for
the study of early tissue development. This type of research can contribute to a better
understanding of miscarriages, infertility, and even birth defects (Wobus & Boheler,
2005; Yu & Thomson, 2008). The studies of the function of certain genes in
development are often conducted by inducing a mutation within a gene suspected to be
involved with these defects. For example, the discovery of the role of Nanog in
maintaining the pluripotent state involved its targeted mutation on homologous
chromosomes (Wobus & Boheler, 2005).
Obstacles to Biomedical Application of ESCs
Although the characteristics of ESCs prove them to be ideal candidates for tissue
engineering and regenerative medicine, many issues must be addressed before their
clinical application. For example, undifferentiated ESCs form tumors known as
teratomas in transplant patients. This is both a mark of their pluripotency and creates a
risk of carcinogenic tumor development (Hentze et al., 2009). There is also the issue of
obtaining a pure homogeneous population of the cell of interest. Additionally, there is
the risk of immunorejection of both ESCs and their derivatives following transplantation
due to mismatched major histocompatibility complexes between patient and donor
(Drukker, 2004).
There is also concern about the genetic instability of ESCs over long periods of
time in culture. Mutations occur naturally in cells, although they occur at lower rates in
ESCs. The accumulation of these mutations over hundreds of cell divisions could lead to
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mutations in important regulatory genes or even lead to the formation of carcinogenic
cells. Also, the culture conditions of ESC cultures can affect the epigenetic modifications
of the cells. For example, serum withdrawal can induce epigenetic modifications that can
negatively affect cell potency and development (Wobus & Boheler, 2005).
Recent data indicates that both ESCs and their derivatives have an
underdeveloped innate immune response, posing a potential problem when transplanted
into the patient where the cells will be challenged by pathogens in the environment
(Wang et al., 2013; Zampetaki et al., 2006; Rajan et al., 2008). Without a competent
innate immune response, these transplanted cells would be defenseless against an attack
from a pathogen, potentially putting the transplant at risk. This thesis research focuses on
this deficiency.
Social and ethical concerns in hESC research and alternatives to hESCs
In addition to the technical issues, there are also ethical concerns involved in stem
cell research. There has been great debate over the rights of human embryos and the
ethics of using them as a source of hESCs. While many members of the public seem to
believe that hESCs are obtained from aborted fetuses, this is not the case. hESCs are
derived from excess embryos produced by in vitro fertilization for couples undergoing
fertility treatment. Hundreds of eggs are fertilized in a petri dish during this process to
form blastocysts. Since only a few of the blastocysts are implanted into the woman’s
uterus, the rest are generally discarded. However, couples are given the option to donate
these excess embryos to research. It is these in vitro fertilized embryos destined for
destruction that are used to isolate hESCs and form hESC cell lines (Lo & Parham, 2009;
Hyun, 2010).
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However, many still feel there is an ethical issue with the destruction of embryos
formed from in vitro fertilization. These people hold the view that even prior to
implantation, embryos possess the same rights as any living individual and destruction of
these embryos for any reason is murder. This belief likely stems from the
misunderstanding that all embryos have the ability to form fully developed organisms,
however, many of these in vitro developed embryos are unlikely capable of this if not
further utilized. Those in support of ESC research argue that these embryos would be
otherwise destroyed making their potential to form human life irrelevant since they would
never be implanted in a uterus (Hyun, 2010).
In 2001, the Bush administration passed legislation supporting the belief that
embryos deserve the rights granted to living individuals due to their potential for life.
This legislation limited the creation of new hESC stem cell lines by permitting federal
funding only to hESC research that utilized hESC stem lines that were already in
existence. This presented many problems considering the possible exposure of these cell
lines to zoonotic viruses from the mouse feeder layers they were grown on and the
increasing amount of genetic mutations. These issues mandated that new hESC lines be
created from excess embryos from in vitro fertilization (Hyun, 2010).
Due to this limitation during the Bush administration, many researchers sought to
find alternatives to the use of hESCs. For example, Meissner and Jaenisch (2006)
developed the altered nuclear transfer technique in which they created mouse embryos
with a knockout for a gene responsible for implantation. These embryos possessed the
ability to produce ESCs, but did not possess the potential to develop a fully formed,
living organism since they were unable to implant onto a uterus or form a trophectoderm.
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However, these cells would still require the use of hESCs as a comparative control before
they could be used as a substitute (Meissner & Jaenisch, 2006; Hyun, 2010).
The development of induced pluripotent stem cells (iPSCs) offers the most
appealing possible alternative to hESCs. iPSCs are differentiated cells that have been
“reprogrammed” to revert back to a pluripotent ESC state. Takahashi and his group
converted mouse fibroblasts to pluripotent stem cells using retroviruses to force the
expression of transcription factors important in maintenance of the stem cell state (Oct
3/4, Sox2, Klf4, and c-myc) in the fibroblasts (Takahashi, 2006). This experiment was
repeated and successful in human somatic cells, forming hiPScs. While it appears these
cells function like hESCs, meaning they are able to differentiate into cells of all three
primary germ layers, there is still concern about the clinical use of these cells. Genetic
differences between iPSCs and hESCs have been detected among other concerns. Until it
is determined these cells are equivalent to hESCs, the use of them and their derivatives in
cell-mediated therapy is questionable and requires systematic investigation (Takahashi et
al., 2007).

Innate Immunity
The Innate Immune Response
To understand the implications of the lack of a developed innate immune response
in ESCs and their derivatives, a brief introduction to the innate immune response is
needed. Innate immunity plays a vital role as a cell’s first line of defense against
microbial attack. The innate immune system consists of mechanisms to detect invading
11

pathogens and activate intracellular signaling pathways that lead to induction of immune
genes to protect the infected cell, fight the pathogen, warn neighboring cells, and activate
the adaptive immune system (Akira et al., 2006).
Cells are able to distinguish between self and non-self molecules via an array of
pattern recognition receptors (PRRs) at the cell surface, in endosomes, or in the cytosol.
Different PRRs bind to broad classes of molecular motifs that are typical of microbes
(termed pathogen associated molecular patterns, or PAMPs). PAMPs are generally
structural components of a pathogen that are necessary for function and are therefore
constitutively expressed by the microbe with little alteration. A common example of a
PAMP would be lipopolysaccharide (LPS), a component of the outer membrane of gramnegative bacterium, or double stranded RNA, which is commonly generated during viral
infection. PAMPs are recognized by PRRs, leading to an innate immune response. PRRs
are constitutively expressed in cells involved in innate immunity such as antigen
presenting cells (dendritic cells and macrophages), B-cells, and structural tissue cells
such as endothelial cells and fibroblasts. Once these PRRs recognize a PAMP, they
induce a signaling cascade, which eventually converges at the point of transcription
factor activation. These transcription factors induce the transcription of immune genes
(Akira et al., 2006).
The immune genes are mostly those encoding cytokines and interferons (IFNs).
Cytokines have a proinflammatory function in the cell, most often characterized as
responding to bacterial infection. Common examples would be interleukin-6 (IL-6) and
tumor necrosis factor α (TNFα). Cytokines promote vasodilation, recruiting more
immune cells to the site of infection (Akira et al., 2006). Type I IFNs (IFNα/β) are more
12

specific toward antiviral responses and directly inhibit viral replication (Huang et al.,
2006). For example, toll-like receptor 3 (TLR3) is a PRR located either on the
membrane of a cell, a phagosome, or an endosome. It recognizes the double stranded
RNA pattern found in viruses followed by recruitment of adaptor proteins, forming a
signaling scaffold that transduces a signal to the point of activating nuclear factors such
as nuclear factor-κB (NF-κB) and IRF-3. These translocate to the nucleus and bind to the
IFNβ promoter, upregulating its transcription. IFNβ is then able to mediate cellular
responses itself by interactions with cellular receptors on other infected cells and
uninfected cells. Through signaling via the JAK-STAT pathway, it is able to upregulate
the transcription of protein kinase R (PKR) and 2’-5’-oligoadenylate synthetase
(2’5’OAS). Once these enzymes have been activated by interaction with double stranded
RNA, they are able to induce cell-mediated effects. PKR phosphorylates eukaryotic
initiation factor 2, inhibiting eukaryotic transcription. This prevents the cell from
transcribing viral DNA. 2’5’OAS activates RNase L, which degrades all mRNA. This
removes viral RNA from the cell, preventing its translation and the production of viral
proteins (Clarke & Tyler, 2009).
Another well-studied receptor involved in innate immunity is TLR4, which
recognizes the lipid A portion of LPS. This TLR is versatile in that it can induce
signaling cascades leading to activation of transcription factors that promote transcription
of both genes coding for type I IFNs and proinflammatory cytokines (Akira et al., 2006).
This brings up an important point that although cytokines and type I IFNs can have
specific effects on a target cell, such as the inhibition of transcription mediated by type I
IFNs in response to viral infection, they more often have the tendency to mediate similar
13

effects on a variety of cells. For example, cytokines IL-6, IL-2, IL-4, IL-5, and IFNγ all
mediate antibody production in B-cells (Kishimoto et al., 1994). This example also
shows that cytokines play an important role in activating the adaptive immune response.
The Role of NF-κB in the Innate Immune Response
The signal transduction of all innate immune responses eventually converges at
the point of NF-κB, a key transcription factor that directly controls the transcription of
Type I IFNs and inflammatory cytokines. Its mechanism of action in differentiated cells
is illustrated in Figure 4. In its inactive form, NF-κB is retained in the cytoplasm by its
association with the inhibitor of NF-κB (IκΒ) (Liang et al., 2004).

Figure 4: NF-κB mediated expression of IFNs and inflammatory cytokines in
differentiated cells

The first step toward NF-κB activation begins with an immune stimulus that
activates a PRR, leading to the phosphorylation of IκB kinase (IKK)

Τhe signaling that


occurs upstream of IKK phosphorylation varies based on the type of PAMP and PRR
interaction initiating the signal. Once its kinase activity is activated, IKK phosphorylates
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IκB. Phosphorylated IκB is then attached to ubiquitin (UUU), a small protein that signals
the degradation of IκΒ. This frees the NF-κB dimer composed of a p50 and p65 subunit.
The p65 subunit contains the conserved Rel homology domain where the nuclear
localization signal is present. Degradation of IκB exposes this nuclear translocation
signal, which induces nuclear translocation of NF-κB. Once it translocates into the
nucleus, it initiates the expression of the genes encoding Type I IFNs (IFNα/β) and
proinflammatory cytokines (Bonizzi & Karin, 2004; Liang et al., 2004) (Figure 4).
Innate Immunity in ESCs and their derivatives
Based on current literature, it appears that both ESCs and their derivatives are
deficient in innate immunity as indicated by the low response of ESCs to pathogens and
cytokines. mESCs were unable to appropriately respond to the LaCrosse Virus (LACV),
as indicated by a lack in production of type I IFNs upon exposure to the virus, unlike
naturally differentiated fibroblasts which greatly upregulate IFN expression (Wang et al.,
2013). A follow up study, however, showed that mESCs were able to respond to
exogenous IFNβ (Wang et al., 2014). Other studies found that both mESCs and their
endothelial cell derivatives have low responsiveness to proinflammatory cytokines,
specifically TNFα (Rajan et al., 2008), and hESCs and their derivatives were unable to
appropriately respond to LPS and other pathogens (Foldes et al., 2010).
This low innate immune response in ESCs could be partially due to low
expression of PRRs and downstream pathway components as has been reported in both
ESCs and their derivatives. Wang et al. (2013) showed that there was no increased
expression of virus-sensing PRRs such as RIG-I, MDA5, and TLR3 upon exposure of
15

mESCs to viral infection. Low levels of TLR3 and MDA5 were also reported in hESCs
in comparison to HeLa cells. RIG-I was expressed in these cells, but many of its
activators were expressed at low levels, while its inhibitors were highly expressed (Chen
et al., 2010).
Although the innate immune dysfunction seems slightly improved with
differentiation, the response is still deficient when compared to naturally differentiated
cells. Since NF-κB is a universal transcription factor in the innate immune response as
well as the converging point of many innate immune pathways, its dysfunction in these
cells could be a molecular basis for this deficiency. A better understanding of the
molecular basis of the lack of innate immune response in ESCs and their derivatives
could contribute to the currently limited knowledge of innate immunity development. It
could also lead to the direction of development of a differentiation method that does
induce innate immune development, increasing the clinical applicability of ESC-DCs.
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RATIONALE, HYPOTHESIS, OBJECTIVES
Due to their properties of pluripotency and self-renewal, ESCs are a promising
source for regenerative medicine and cell therapy. Recent studies have demonstrated that
mESCs can be differentiated to several cell types, including endothelial cells, smooth
muscle cells, and neurons with expected morphology (Rajan et al., 2008; Guo et al.,
2007). However, ESCs and their derivatives are not fully functional when compared to
their in vivo counterparts; of particular concern is the recent finding that ESCs and their
derivatives appear to have an attenuated immune response.
A recent study in our lab demonstrated that although susceptible to the cytopathic
effect of viral infection, mESCs are deficient in expressing IFNα/β and cytokines, the
hallmark of antiviral response and innate immunity (Wang et al., 2013). This study
exemplifies that ESCs have a deficient innate immune response. Other laboratories have
found similar results confirming this concerning deficiency in ESCs. Zampetaki et al.
(2006) showed that mESCs have an underdeveloped immune response to bacterial
challenges. It was also found that endothelial cells derived from ESCs have this
deficiency (Zampetaki et al., 2006). These findings indicate a lack of developed innate
immunity in ESC derivatives. This has led to the conclusion that current methods of
differentiation are inadequate for promoting the development of innate immunity in vitro.
If these cells lack a full immune response, they could be more susceptible to pathogens
they encounter, potentially compromising the patient’s health.
A greater understanding of the molecular mechanisms controlling innate
immunity could contribute to the establishment of a method to promote innate immunity
development during in vitro differentiation. My project aimed to explain the molecular
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basis of this innate immune deficiency, an aspect of this problem that has yet to be
addressed. Based on the finding that ESCs fail to express IFNα/β and IL-6 in response to
viral and bacterial challenge, I hypothesized that NF-κΒ was not activated by immune
stimuli in ESCs, which may explain the failure of these cells to produce Type I IFNs and
cytokines (Wang et al., 2013; Zampetaki et al., 2006). NF-κB seems like a likely candidate
due to its role as a universal regulator of gene expression involved in the innate immune
response. It controls the transcription of many immune response genes including type I
IFNs and inflammatory cytokines (Liang et al., 2004). Considering endothelial cells
derived from ESCs also had an attenuated immune response (Zampetaki et al., 2006), it is
likely that NF-κΒ may not be fully functional in ESC-DCs. To test this hypothesis, I
analyzed the function of the NF-κΒ pathway in ESCs and ESC-fibroblasts (ESC-FBs) and
compared them with naturally differentiated fibroblasts where NF-κΒ is strongly activated.
Although this study only focused on one of the many pathways involved in the innate
immune response, a further understanding of this pathway could greatly contribute to the
limited knowledge currently available about innate immunity development during
differentiation. This could be instructive in obtaining ESC-DCs for clinical application.
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EXPERIMENTAL DESIGN AND METHODS
Experimental design
To carry out this study, I used multiple cell types and several well-established
molecular techniques. D3 cells, a commonly used mESC line, and fibroblasts derived
from D3 cells (termed D3-FBs), were treated with a known activator of the NF-κB
pathway, the proinflammatory cytokine TNFα. Naturally differentiated fibroblasts (C3H)
were used as a positive control. Fibroblasts are an excellent model for the study of
immunity due to their fully developed innate immune response, production of
extracellular matrix, presence in most tissues, and the ease with which they can be
differentiated from ESCs. Immunostaining was used to determine NF-κB’s subcellular
localization, hence its activation. In stimulated cells, NF-κB will translocate into the
nucleus of the cell where it can upregulate expression of targeted genes. The basal
expression levels of receptors involved in inducing signal transduction leading to NF-κB
activation were measured. The expression levels of NF-κB pathway receptors involved in
viral recognition (RIG-I and TLR3), bacterial recognition (TLR4 and CD14), and
cytokine recognition (TNFR2) were assayed by real-time quantitative polymerase chain
reaction (RT-qPCR). The activation of NF-κB was further determined by the induction of
gene expression under its control. The expression levels of the products of this pathway
such as the proinflammatory cytokine IL-6 and the cellular adhesion molecules
intracellular adhesion molecule-1 (ICAM-1) and vascular cellular adhesion molecule-1
(VCAM-1) were assayed by RT-qPCR. The principles of the aforementioned techniques
and methods are discussed below.
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Cell Culture Techniques
Background
Cell culture is when cells are isolated from the tissue of an organism. Isolated
cells are typically grown in a culture dish filled with media providing the appropriate
environment and nutrients to support growth. Cell culture is a valuable technique that
became common among research labs in the 1950s. The advent of antibiotics helped
prevent contamination. The use of enzymes such as trypsin enabled dissociation of cells
from their culture dish, allowing the continuous growth of transformed or continuous cell
lines. Through further research, a defined medium able to more efficiently support cell
growth was created. Finally, the commercialization of technology such as laminar flow
hoods, aseptic disposable materials, and cell media made the use of cell culture
commonplace (Ryan, 2008).
When cells are first obtained and grown in culture in a supportive artificial
environment, this is called a primary culture. Eventually, the cells will fill the culture
dish and must be subcultured. This requires the use of enzymes such as trypsin to
carefully detach the cells from the culture dish, followed by replating of the cells at a
lower density. Any extra cells can be stored in a cryoprotective agent such as
dimethylsulfoxide or glycerol at temperatures below -130°C until later use (Ryan, 2008).
Another requirement for most cells is attachment factors. Most cells derived from
normal tissues or organs are anchorage-dependent, meaning that they must be attached to
a substrate in order to proliferate. To accommodate these cells, cell culture dishes are
often coated with substances such as collagen or gelatin. The culture medium also must
provide appropriate nutrients, maintenance of an appropriate pH (7.0-7.4), osmolality,
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and growth factors and hormones (often supplied in the form of a 5-20% concentration of
animal serum such as fetal bovine serum). Cells are stored at a temperature near the body
temperature of the organism from which they were obtained, generally 37°C (Ryan,
2008).
ESC Culture
D3 and DBA252 cell lines were maintained in Dublecco’s modified Eagle
medium (DMEM) supplemented with 15% fetal bovine serum (FBS), 1000 U/mL of LIF,
non-essential amino acids, 100U/mL penicillin, and 100μg/mL of streptomycin. Culture
dishes were coated with 0.1% gelatin and stored in a humidified incubator at 37°C in an
atmosphere at 5% CO2. When the cells began to crowd the culture dish, they were
subcultured. Briefly, trypsin, phosphate buffered saline (PBS), and DMEM containing
15% FBS were heated for 5-10 minutes at 37°C. A suction pipette was used to remove
old medium. Enough PBS to cover the bottom of the dish was then added to wash the
cells, and PBS was removed using a suction pipette. Trypsin was added to the culture
dishes to gently detach the cells, and after cells were detached, an equal volume of 15%
FBS DMEM was then added to inactivate the trypsin. Cells were then transferred to 1.5
mL tubes and centrifuged at 1,100 rpm for 3.5 minutes. A suction pipette was then used
to remove the supernatant, and the cell pellet was resuspended in 1 mL of fresh medium.
Cells were then replated to new gelatin-coated dishes at 50-60% confluence and
maintained as described above.
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C3H10T1/2 Fibroblast Culture
C3H10T1/2 cells (A fibroblast cell line isolated from 14 day mouse embryos,
hereafter referred to as C3H) were cultured in DMEM containing 10% FBS, 100U/mL
penicillin, and 100μg/mL of streptomycin. These cells were kept at 37°C in a
humidifying incubator in an environment of 5 % CO2. The subculture procedure was
identical to that of ESCs, except culture dishes were not coated with 0.1% gelatin as
fibroblasts adhere well to plastic.
In Vitro Differentiation of ESCs to fibroblasts
mESCs (D3 or DBA cell lines) were seeded to 0.1% gelatin-coated tissue culture
dishes and grown in a monolayer. The cells were treated with 1 μM retinoic acid (a
vitamin A derivative that promotes differentiation) for 10 days, refreshing the medium
every 3 days. This resulted in a mixed population of cell types including a large
proportion of fibroblasts. The cells were then trypsinized and re-seeded to uncoated tissue
culture dishes, and the medium was refreshed after 30-45 minutes to remove unattached
cells. The remaining cells displayed typical fibroblast morphology and marker
expression. These differentiated cells are referred to as either D3-FBs or DBA-FBs,
depending on the ESC line from which they were derived. Fibroblast cells were
maintained in the same conditions described for C3H cells (Wang et al., 2013).
These cells were differentiated into fibroblasts due to their role in innate
immunity. Although fibroblasts are an important source of extracellular matrix proteins
necessary to maintain connective tissue, they also play a major role in vascular
inflammation. The main components of vascular inflammation are the activation of local
endothelial cells and the recruitment of leukocytes circulating the blood to the site of
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infection or inflammation. It appears that fibroblasts play a major role in this by acting as
a virtual alert system, producing proinflammatory molecules upon exposure to a pathogen
leading to activation of endothelial cells and recruitment of leukocytes (Enzerink and
Vaheri, 2011).

Immunostaining and Microscopic Analysis
Principle of Immunostaining
Immunostaining is based on the principles of immunohistochemistry, which
depends on antibody-antigen interactions with high affinity and avidity. Antibodies are
produced by B-cells in the body in defense against invading pathogens. Antibodies are
highly specific for foreign molecules known as antigens present on these pathogens. In
immunostaining, an antibody specific for the protein of interest is used to treat fixed cells.
This antibody is labeled with a fluorophore that will emit light when exposed to a certain
wavelength of light under a fluorescent microscope (Koivunen & Krogsrud, 2006).
There are two methods used in immunostaining to fluorescently label the targeted
molecule: direct and indirect. In the direct method, a single fluorescently labeled
antibody made against the desired protein is used to label the desired protein. In the
indirect method, two antibodies are used. The primary antibody is specific for the
antigen of interest but is not fluorescently labeled. The secondary antibody, however, is
fluorescently labeled and is specific to the primary antibody raised against the animal in
which the primary antibody was raised. The indirect method allows for amplification of
the fluorescent signal by limiting the possibility of cross reactivity by the fluorescently
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labeled antibody and allowing multiple secondary antibodies to bind to a single primary
antibody (Figure 5) (Koivunen & Krogsrud, 2006).

Figure 5: Comparison of direct method of immunostaining (I) and indirect method of
immunostaining (II) (adapted from Koivunen & Krogsrud, 2006).

Immunostaining Protocol
Cells were fixed with methanol for 15 minutes. Methanol causes denaturing of
cellular proteins, allowing for entry of antibodies into the cell. Fixation also maintains
the cell structure and integrity after biological processes have halted. Methanol was then
removed, and PBS was added allowing cells to be stored at 4°C until needed. Blocking
buffer composed of 2% bovine serum albumin (BSA) in Tris-buffered saline with Tween20 (TBST) was then added to the cells for thirty minutes. The blocking step prevents
non-specific interactions of antibodies therefore limiting background staining. The cells
were then incubated with a primary antibody raised against the targeted molecule in a
1:100 dilution in 2% BSA for two hours at room temperature. The cells were then
washed in TBST three times for two minutes each to remove any free, excess antibody.
The cells were then incubated with the fluorescently labeled secondary antibody specific
for the primary antibody. This incubation was left in the dark at room temperature for
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two hours. The cells were then washed in TBST three times again. 20 μL of mounting
medium was placed on a new, appropriately labeled microscope slide. The coverslips
were then placed on the mounting medium drops, cell side down. Two coats of nail
polish were applied to seal the coverslips on the slides. The slides were then stored in the
dark at 20°C until viewed. Slides were examined using a Zeiss LSM 5-10 laser scanning
confocal microscope. The obtained images were analyzed using Zeiss LSM Image
Examiner Software.
Immunostaining to Detect Nuclear Translocation of NF-κB by Confocal Microscopy
ESCs, C3H cells, D3-FBs, and DBA-FBs passaged 8 times (p8) were cultured
following the cell culture protocol. One set of each cell type received no treatment to act
as a control. Cells were grown on cover glasses which were kept in a 24 well container
in 0.5 mL of 15% FBS DMEM until they reached 100% confluence. One set of each cell
type was switched to 2% FBS medium for about 15 hours prior to a 15-minute treatment
of TNFα at a concentration of 20ng/mL. Control cells from each cell type (C3H, D3FBs, and DBA-FBs) and cells treated with TNFα 15’ from each cell type were blocked
using 2% BSA. They were then treated with the primary antibody- polyclonal rabbit
anti-NF-κB p65 (Santa Cruz, Biotechnology) diluted to a concentration of 1:100 in 2%
BSA for about two hours. After washing with TBST, these cells were treated with the
secondary antibody- goat anti-rabbit IgG-Texas Red: (Santa Cruz, Biotechnology,)
diluted to a concentration of 1:100 in 2% BSA for about two hours. These cells were
then mounted using mounting medium and viewed on the fluorescent confocal
microscope using the laser at the wavelength of 543nm (rhodamine/Texas red).
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Immunostaining to Characterize ESC-FBs
Four untreated cell samples of D3-FBs were blocked using 2% BSA. One cell
sample was treated with the primary antibody- polyclonal rabbit anti-NG2 chondroitin
sulfate proteoglycan IgG at a concentration of 1:100 in 2% BSA for about 2 hours. This
culture was then treated with a secondary antibody- goat anti-rabbit IgG-FITC at a
concentration of 1:100 in 2% BSA for about 2 hours (Santa Cruz, Biotechnology). One
culture was treated using the same conditions and antibody concentrations with the
primary antibody- goat anti-type IV collagen polyclonal antibody (Santa Cruz,
Biotechnology) and a secondary antibody- goat anti-goat IgG-FITC (Santa Cruz,
Biotechnology). Another culture was treated using the same conditions and antibody
concentrations using a primary antibody- Mouse Anti-MMP-14 [MT1-MMP] monoclonal
antibody (Santa Cruz, Biotechnology) and a secondary antibody goat anti-mouse IgGFITC (Sant Cruz, Biotechnology). The other cell culture was treated with a primary
antibody- mouse anti-Ncadherin (Santa Cruz, Biotechnology) and a secondary antibodygoat anti-mouse IgG-FITC (Santa Cruz, Biotechnology). These cells were mounted
using mounting medium with DAPI and later viewed on the fluorescent confocal
microscope using the following lasers: 405 nm (DAPI) and 488 nm (FITC). DAPI
staining allows for visualization of the nucleus.

26

RNA Extraction and RT-qPCR
Principle of PCR-based Gene expression analysis
RT-qPCR allows for the measure of DNA amplification as it occurs due to the
presence of a molecule that fluoresces when it binds to double stranded DNA. As DNA
is amplified and double stranded DNA accumulates so does fluorescence. A common
fluorescent DNA binding chemical used is SYBR green. As shown in Figure 6, there are
four phases that occur during RT-qPCR: ground phase, early exponential phase, loglinear phase, and plateau phase. During the ground phase, amplification is just beginning
and enough double stranded DNA is not yet present to produce a detectable increase in
fluorescence. During early exponential phase, a high enough concentration of double
stranded DNA is present to produce a detectable increase in fluorescence. The cycle at
which early exponential phase occurs is referred to as the Ct, which is indicated by the
red arrow in Figure 6. The Ct value is assumed to be equivalent to the amount of copy
DNA originally in the sample. During the log linear phase, the DNA within the sample
undergoes its most efficient replication, ideally doubling the amount of DNA present
with every cycle. During the plateau phase, DNA replication begins to slow down and
eventually end due to depletion of necessary resources such as nucleotides (dNTPs).
Using the Ct values, the relative expression of the genes of interest can be determined by
comparison to a housekeeping gene, a gene that is constitutively expressed in the cells
being tested. These are genes such as β-actin and GADPH. A commonly used method of
analysis is the comparative Ct method, which uses a formula to find the fold change using
a ratio between the relative expressions of the gene of interest compared to the
housekeeping gene. The formula is as follows (Wong & Medrano, 2005) (Pfaffl, 2001):
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𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑖𝑖𝑖𝑖 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 2(𝐶𝐶𝐶𝐶 𝑟𝑟𝑟𝑟𝑟𝑟−𝐶𝐶𝐶𝐶 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 𝑜𝑜𝑜𝑜 𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖)𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑎𝑎𝑙𝑙
=
𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑖𝑖𝑖𝑖 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔
2(𝐶𝐶𝐶𝐶 𝑟𝑟𝑟𝑟𝑟𝑟−𝐶𝐶𝐶𝐶 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 𝑜𝑜𝑜𝑜 𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖)𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

Figure 6: Phases of RT-qPCR. The Ct value is indicated by the red arrow (adapted from
Wong & Medrano, 2005)

RNA Extraction
RNA was isolated from cells using Sigma Tri-reagent. 0.6 mL of Tri-reagent was
added per 28cm2 area of culture dish; Tri-reagent was added directly to culture. The cells
were then collected and transferred into 1.5 mL microfuge tubes. 0.2 mL of chloroform/
mL of Trizol was added and the tube was vortexed for 15 seconds. The sample was then
incubated at room temperature for 10 minutes. The sample was then centrifuged at
10,000 rpm for 10 minutes at 4°C. This led to a phase separation. The RNA was present
in the aqueous phase, which was removed and placed in a new tube. The protein was in
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the interphase or flocculent as it was attracted to both the organic and aqueous phases due
to the amphipathic nature of proteins. The DNA migrated to the organic phase or
flocculent due to the acidic environment and presence of phenol: chloroform. The H+
neutralizes the phosphate groups on DNA making it without charge and therefore
nonpolar and attracted to the organic and interphase. 0.5 mL of 100% isopropanol was
added per mL of Tri-reagent used for homogenization (0.5 mL if 1 mL Tri-reagent used).
The sample was left to incubate at room temperature for ten minutes. Following
incubation, the sample was centrifuged at 12,000 rpm for 15 minutes at 4°C. The
supernatant was removed from the tube, leaving only an RNA pellet. The pellet was
washed with 1 mL of 75% ethanol per 1 mL of Tri-reagent used in initial homogenization
(1 mL used if 1 mL Tri-reagent used). The sample was left in the -20°C freezer for at
least one hour to allow for RNA precipitation. The sample was centrifuged at 1200 rpm
for 15 minutes at 4°C and the ethanol was discarded. The RNA pellet was left to air dry
for 5-10 minutes on ice without allowing the pellet to be over dried. The pellet was
resuspended in DEPC water. The concentration and integrity (A260/A280 was between 1.82.2) of RNA was determined using a spectrophotometer. The sample was stored at -70°C
until later use.
Reverse Transcription Protocol
In order to generate the cDNA to be quantified by PCR amplification, reverse
transcription of total RNA was performed. The RNA sample was then reverse
transcribed using M-MLV reverse transcriptase. The RNA was diluted in DEPC water to
an 11.5μL total volume at 1μg/μL. 1μL of dNTPs (10μM) and 2μL of random hexamers
primer (10X) were added to the sample. The sample was then incubated at 70°C for five
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minutes then stood on ice. 4μL of 5X M-MLV buffer, 1μL of M-MLV reverse
transcriptase, and 0.5mL of RNase inhibitor were added to the sample. The sample was
incubated in the thermal cycler at 42°C for one hour, then 10 minutes at 95°C to
inactivate the enzyme. 200μL of DEPC water was added to the now cDNA sample
which was stored at -20°C until needed.
Quantitative PCR protocol
A 20 μL volume reaction was made for each sample composed of: 10 μL of 2X
SYBR mix, 3 μL of DEPC water, 5 μL of cDNA and 2 μL of the appropriate primer (a
primer specific for the gene of interest). The samples were then analyzed using qPCR that
was run for 40 cycles. The data was analyzed using the comparative Ct method and all
data was relative to β-actin expression (Pfaffl, 2001). The sequence of the β-actin
primers were as follows:
Forward Primer: 5’-CATGTACGTAGCCATCCAGGC-3’
Reverse Primer: 5’-CTCTTTGATGTCACGCACGAT-3’
Analysis provided the relative RNA levels, and therefore expression level, of the gene of
interest.
Determination of PRR Expression levels
RT-qPCR was used to determine the basal level of expression of common PRRs
in p5 D3-FBs and C3H cells. The following primers were used to test the expression
levels of the following PRRs:
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Gene
RIG-I
MDA5
TLR3
TLR4
CD14
TNFR2

Forward Primer Sequence

Reverse Primer Sequence

5’-ATTCAGGAAGAGCCAGAGTGTC-3’

5’-GTCTTCAATGATGTGCTGCAC-3’

5’-CGATCCGAATGATTGATGCA-3’

5’-AGTTGGTCATTGCAACTGCT-3’

5’-CTTGCGTTGCGAAGTGAAGAA-3’

5’-CCAATTGTCTGGAAACACCCC-3’

5’-TGCACTGAGCTTTAGTGGTTGC-3’

5’-GACCCATGAAATTGGCACTCAT-3’

5’-CTCTGTCCTTAAAGCGGCTTAC-3’

5’-GTTGCGGAGGTTCAAGATGTT-3’

5’-GCCCAGGTTGTCTTGACA-3’

5’-CACAGCACATCTGAGCCTTCC-3’

Determination of NF-κB Targeted Gene Expression Level
RT-qPCR was used to determine the expression of TNFα induced NF-κB targeted
genes. D3-FBs (p9) and DBA-FBs (p10) and C3H cells were treated with 20 ng/ml
TNFα in 2% FBS DMEM for 24h. The following primers were used to test the
expression levels of the following NF-κB targeted genes:
Gene

Forward Primer Sequence

ICAM-1

5’-GGCATTGTTCTCTAATGTCTCCG-3’

5’-GCTCCAGGTATATCCGAGCTTC-3’

VCAM

5’-CCAAATCCACGCTTGTGTTGA-3’

5’-GGAATGAGTAGACCTCCACCT-3’

IL-6

Reverse Primer Sequence

5’-TAGTCCTTCCTACCCCAATTTCC-3’
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5’-TTGGTCCTTAGCCACTCCTTC-3’

RESULTS
Characterization of ESC-FBs
Fibroblasts play a major role in the innate response, especially in vascular
inflammation. These cells produce proinflammatory molecules upon exposure to a
pathogen leading to activation of endothelial cells and recruitment of leukocytes.
Fibroblasts produce many molecules important to the immune response, including
cytokines such as interleukins and interferons (Enzerink & Vaheri, 2011). They also
produce cellular adhesion molecules such as ICAM-1, important in recruiting leukocytes
to the site of infection (Zittermann & Issekutz, 2006). Murine embryonic fibroblasts
(MEFs) have also been shown to highly express receptors, such as TLRs and have been
used to characterize these receptors (Kurt-Jones et al., 2004). Together, all of these
qualities make fibroblasts an ideal model for the study of innate immunity.
Fibroblasts were differentiated from ESCs by the method utilizing retinoic acid.
To confirm the mESC-FBs were in fact fibroblasts, they were first compared to the
naturally differentiated fibroblast cell line C3H, which are derived from early mouse
embryos (Wang et al., 2013). Using the toluidine blue stain, the morphologies of C3H
cells and D3-FBs were compared. This data is shown in Figure 7A. D3 ESCs exhibited
typical ESC morphology. The cells had a round shape with small cell bodies in culture.
However, the D3-FBs exhibited morphology similar to C3H cells. They had a more
elongated and flattened cell body. In addition to morphology, some fibroblast markers
were expressed in D3-FBs as detected by immunostaining and confocal microscopy. The

32

markers used were: neural cadherin (NCAD), neural antigen 2 (NG2), and collagen 4
(Col4) (Figure 7B).

Figure 7: Characterization of ESC-FBs. A: Toluidine blue staining of methanol fixed
D3-ESCs, C3H cells, and D3-FBs. B: Fibroblast markers were analyzed using
immunostaining in D3-FBs. The indicated proteins were identified with their specific
antibodies and detected with secondary antibodies labeled with FITC (green). The
nucleus was stained with DAPI (blue).

Expression of PRRs in ESCs, D3-FBs s, and C3H cells as Measured by RT-qPCR
Since the attenuated immune response observed in ESCs could be due to a low
expression of PRRs, leading to an inability of these cells to recognize and respond to
pathogens, the expression levels of PRRs involved in viral, bacterial, and cytokine
recognition were analyzed in ESCs, D3-FBss, and C3H cells. These PRRs should be
highly expressed in fibroblasts considering MEFs have been shown to highly express
TLRs (Kurt-Jones et al., 2004). Increased expression of these receptors in ESC-FBs
could indicate increased functionality of the innate immune response following
differentiation.
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As shown in Figure 8, expression of all PRRs in ESCs was extremely low when
compared to expression levels in D3-FBs and C3H cells. However, this expression
increased following differentiation, although most PRRs were still not expressed as
highly as in naturally differentiated C3H cells. The only PRRs that were expressed at
similar levels to C3H cells in D3-FBs were TNFR2, CD14, and MDA5.

Expression relative to B-actin
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0.01

0.008

ESC
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0.002
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TLR4
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Figure 8: Basal PRR expression in ESCs, D3-FBs, and C3H cells. RT-qPCR in p5 D3FBs and C3H cells determined the basal mRNA levels of several PRRs. The values are
means ± SD of three independent experiments.

Determination of NF-κB Nuclear Translocation by Immunostaining and
Microscopic Analysis
A well-established method to determine NF-κB activation is by immunodetection of

its cellular location. In unstimulated cells, NF-κB is mainly detected in the cytoplasm.
TNFα treatment induces the translocation of NF-κB to the nucleus. This method was
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utilized to determine the functionality of the NF-κB pathway in ESCs, ESC-FBs, and C3H
cells. Since NF-κB is a universal regulator of many genes involved in the innate immune
response, its functionality is a good reflection of the functionality of the innate immune
response itself. Therefore, this experiment sought to determine if there was increased NFκB activity, and therefore a more developed innate immune response in ESC-DCs.
Treated cells were first incubated with anti- NF-κB antibodies followed by a
treatment of a secondary, rhodamine-conjugated antibody specific for the anti- NF-κB
antibody, and analysis by fluorescence confocal microscopy. The results, shown in
Figure 9, confirm that TNFα did not induced nuclear translocation of NF-κB in ESCs
since the fluorescence is seen entirely in the cytoplasm in both TNFα treated and control
ESCs. This correlates with the previous results (Figure 8) showing low expression of
PRR receptors in ESCs. These results indicate that NF-κB is not functional in ESCs.
Although expression of PRRs is generally lower in ESC-FBs than in naturally
differentiated C3H cells (Figure 8), it seems that nuclear translocation of NF-κB is
functional. This can be seen by the fact that fluorescence is detected in the nucleus of
D3-FBs upon treatment with TNFα rather than in the cytoplasm as seen in the control.
This is the same as the results in C3H cells. This result was confirmed in DBA-FBs.
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Figure 9: TNFα induced NF-κB translocation. ESCs, D3-FBs, DBA-FBs, and C3H cells
were treated with TNFα (20ng/mL) for 15’ in 2% FBS DMEM and stained for NF-κB.
The subcellular location of NF-κB was then visualized by confocal microscopy
(mag=400X).

TNFα Induced Expression of NF-κB regulated Genes in ESCs, C3H and ESC-FBs
Following nuclear translocation of NF-κB, it acts as a transcription factor, binding
to the promoters of many genes important in the innate immune response, and
upregulating their expression by increased transcription. To determine the functionality
of translocated NF-κB at upregulating expression of its targeted genes, the expression
levels of these genes in TNFα treated cells were determined.

36

Using RT-qPCR, the expression levels of ICAM-1, VCAM, and IL-6 by
TNFα treatment in cells were determined. These results are shown in Figure 10. Despite
the functionality of NF-κB nuclear translocation in ESC-FBs, the upregulation of NF-κB
targeted gene ICAM-1 in response to TNFα was lower than in naturally differentiated
C3H cells. However, the mRNA fold change of VCAM and IL-6 were relatively similar
in all cell types, which were low in all cells tested. ICAM-1 expression was increased
about 100 fold in C3H cells, but it was only approximately increased by 10 fold in D3FBs and DBA-FBs. This is about one fifth of the fold change seen in C3H cells.
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Figure 10: The induction of ICAM-1, VCAM, and IL-6 mRNA by TNFα treatment was
determined by RT-qPCR at 24 h post treatment. D3-FBs (p9) and DBA-FBs and C3H
cells were treated with 20 ng/ml TNFα in 2% FBS DMEM for 24h. The results are
expressed by mRNA fold change, and mRNA levels in the control cells are designated as
1. The values are means ± SD of two independent experiments.

37

DISCUSSION
This study sought to obtain a better understanding of the molecular mechanism
underlying the attenuated innate immune response to viruses and cytokines in mESCs and
their derivatives. While it is understood that mESCs and their derivatives have an
attenuated immune response, the underlying molecular mechanisms are unclear. Since
innate immune signaling eventually converges at the point of NF-κB, my project focused
on understanding if a defect in this pathway is contributing to this dysfunction in mESCs
and their differentiated cells in response to TNFα.
Based on the finding that ESCs fail to express IFNα/β and IL-6 in response to viral
and bacterial challenge (Wang et al., 2013), it was hypothesized that NF-κΒ was not
activated by immune stimuli in ESCs, offering an explanation for the failure of these cells to
produce Type I IFNs and cytokines. Since the derivatives of mESCs were also unable to
mount an appropriate immune response to TNFα (Rajan et al., 2008), it was also
postulated that the NF-κB pathway was defective in mESC derivatives as well.
Confirmation of these findings would indicate differentiation conditions were inefficient
at upregulating NF-κB pathway development.
In this study, the function of the NF-κΒ pathway in ESCs and ESC-DCs was
analyzed. ESC-FBs were specifically used due to the role of fibroblasts in tissue
inflammation and their sensitivity to the stimulation of cytokines such as TNFα (Enzerink
and Vaheri, 2011; Kurt-Jones et al., 2004).
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The first aspect of the NF-κB pathway examined was the pathway receptors.
Since ESCs and their derivatives seem to be defective in responding to microbes, viruses,
and cytokines, receptors recognizing each of these were selected. The expression levels
of receptors recognizing dsRNA PAMP of viruses (RIG-I, MDA5, and TLR3) were
barely expressed in mESCs (Figure 8). This is expected based on previous studies
showing that these three PRRs were not expressed even when exposed to LACV (Wang
et al., 2013). Although there was some increase in expression of these PRRs after
differentiation, the expression was lower than in C3H cells. This pattern remained
constant for TLR4 (a receptor recognizing LPS of bacteria) expression as well, which is
in agreement with previous studies (Foldes et al., 2010; Zampetaki et al., 2006).
However, previous studies had shown TNFR2, a receptor recognizing TNFα, was
expressed at low levels in mESCs and their retinoic acid differentiated derivatives when
compared to naturally differentiated cells (Kim et al., 2008). This result was confirmed
in hESCs and their retinoic acid differentiated derivatives (Kang et al., 2007). This,
however, was not a reflection of our results. Our results indicated that retinoic acid
induced differentiation to fibroblasts (D3-FBs) was enough to induce TNFR2 expression
to the same levels of C3H cells. This was the same pattern seen in CD14 expression,
another bacterial PRR. This inconsistency could be due to the use of different cell lines
in these two studies.
Low basal expression of pathway receptors in mESCs could be a great contributor
to innate immune dysfunction. This low expression could prevent the necessary
PRR/PAMP interaction to initiate activation of the NF-κB pathway. This activation was
determined by detection of the subcellular location of NF-κB by immunostaining and
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microscopic analysis. As shown in Figure 9, when treated with TNFα, mESCs retained
NF-κB in the cytoplasm, indicating the pathway was not activated by cytokine exposure.
However, the mESC-FBs (D3-FBs and DBA-FBs) showed nuclear translocation of NFκB upon exposure to TNFα similar to the nuclear translocation seen in C3H. These
results seem to indicate that despite the lower expression of most TLRs seen in mESCFBs (D3-FBs and DBA-FBs) in comparison to C3H cells, the NF-κB pathway seems to
become functional following differentiation. This would indicate that differentiation
alone is enough to induce innate immunity development at least in regards to NF-κB
nuclear translocation.
However, when the expression levels of NF-κB regulated genes in response to
TNFα treatment were examined by RT-qPCR, the induction of the gene ICAM-1 in the
mESC-FBs (D3-FBs and DBA-FBs) was significantly lower than in C3H cells. As
shown in Figure 10, the mRNA fold change of ICAM-1 in mESC-FBs was one fifth that
of the fold change seen in naturally differentiated fibroblasts. Expression of this
molecule is strongly induced by TNFα treatment in fibroblasts (Shan et al., 2010). While
expression of VCAM and IL-6 seemed to be relatively consistent throughout all cell
types, the response was less than ten fold in all cell types as well, indicating that these
particular cells may just weakly upregulate these genes in response to TNFα.
The results indicate that the dysfunction of the NF-κB pathway seems to occur at
the steps downstream of NF-κB translocation, specifically in upregulation of ICAM-1.
This raises the question: why is NF-κB not promoting gene expression of ICAM-1? It
can be speculated that the ICAM-1 promoter activity is mediated by epigenetic
40

modifications. This would be similar to what Zampetaki et al. (2006) found in relation to
the TLR4 promoter. They discovered that this promoter was methylated in ESCs and
their endothelial derivatives, which prevents transcription. Another possible explanation
is that there is some sort of defect in the NF-κB binding activity, preventing it from
appropriately binding to the ICAM-1 promoter.
Overall, my results confirmed the finding of many others that the NF-κB pathway
is not functional in mESCs, but is induced to some extent by current differentiation
methods, as exemplified by the NF-κB nuclear translocation data. However, the
functionality of the NF-κB pathway is not equivalent to that found in their naturally
differentiated counterparts. This deficiency is likely due to differentiation methods that
do not provide the specific environment or factors required to induce complete activation
of NF-κB regulated gene expression. Since more than one transcription factor is often
involved in the transcriptional activation of a gene, it could be a dysfunction in another
pathway contributing to this attenuated ICAM-1 expression. For example, the
transcription factor AP-1, activated by the MAP-kinase pathway appears to be involved
in regulating innate immune gene expression (Rajan et al., 2008). At the present time, it
is not clear if this pathway is functional in ESCs and ESC-DCs.
Although more research needs to be conducted to understand the exact molecular
mechanisms underlying the innate immune deficiency seen in ESCs and their derivatives,
it seems that NF-κB dysfunction, downstream of its nuclear translocation, may play a
role in this mechanism. Although this study only focused on some aspects of the NF-κB
pathway’s involvement in the innate immune response, a further understanding of this
pathway and its role in the development of innate immunity could greatly contribute to the
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limited knowledge currently available about innate immunity development in ESCs.
Through further experimentation, I expect that a novel differentiation strategy will be able to
generate ESC derivatives with an activated NF-κΒ pathway, making their potential for use
in regenerative medicine even greater.
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